SCHEMBL4061960

SCHEMBL4061960

CN1CCCNS1(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL791484 0.84
SCHEMBL11930024 0.70 PER2 (0.33)
SCHEMBL13684368 0.70 PER2 (0.31)
SCHEMBL11936466 0.70 PER2 (0.40)
SCHEMBL22148462 0.67 PER2 (0.35)
SCHEMBL13622572 0.66 PER2 (0.47)
SCHEMBL15380715 0.64 OPRL1 (0.34)
SCHEMBL762827 0.64 PER2 (0.34)
SCHEMBL13154123 0.64 PER2 (0.31)
SCHEMBL761380 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12564547-B2 Compositions, formulations, and methods for skin treatment ODDITY LABS, LLC (US) 2026-03-03 US disclosed
US-12264138-B2 Process for the preparation of microbiocidal oxadiazole derivatives SYNGENTA CROP PROTECTION AG (CH) 2025-04-01 US disclosed
US-20230240960-A1 COMPOSITIONS, FORMULATIONS, AND METHODS FOR SKIN TREATMENT ODDITY LABS, LLC 2023-08-03 US disclosed
US-20230240960-A1 COMPOSITIONS, FORMULATIONS, AND METHODS FOR SKIN TREATMENT ODDITY LABS, LLC 2023-08-03 US disclosed
WO-2023133240-A1 COMPOSITIONS, FORMULATIONS, AND METHODS FOR SKIN TREATMENT REVELA, INC. (US) 2023-07-13 WO disclosed
EP-3668839-B1 HETEROCYCLIC INHIBITORS OF ATR KINASE UNIV TEXAS (US) 2023-04-12 EP disclosed
US-20230075856-A1 CYCLIC SULFAMIDE COMPOUNDS FOR TREATMENT OF HBV ASSEMBLY BIOSCIENCES INC (US) 2023-03-09 US disclosed
WO-2022221704-A1 COMPOUNDS, COMPOSITIONS AND METHODS OF TREATING CANCER HOTSPOT THERAPEUTICS, INC. (US) 2022-10-20 WO disclosed
WO-2022140390-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2022-06-30 WO disclosed
US-20220194907-A1 PROCESS FOR THE PREPARATION OF MICROBIOCIDAL OXADIAZOLE DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2022-06-23 US disclosed
EP-1326865-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-07-16 EP disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed
WO-2002030930-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-04-18 WO disclosed
EP-0501568-B1 Substituted cyclic sulphamide derivatives MERCK SHARP & DOHME (GB) 1997-08-20 EP disclosed
EP-0596109-B1 SULFAMIDOSULFONAMIDE DERIVATIVES AND HERBICIDES NISSAN CHEMICAL IND LTD (JP) 1996-12-18 EP disclosed
EP-0596109-A1 SULFAMIDOSULFONAMIDE DERIVATIVES AND HERBICIDES. NISSAN CHEMICAL IND LTD (JP) 1994-05-11 EP disclosed
US-5194440-A Treatment for migraine; selective agonist MERCK SHARP & DOHME LTD. (GB) 1993-03-16 US disclosed
US-5152824-A Selective for crop usage NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-10-06 US disclosed
EP-0501568-A1 Substituted cyclic sulphamide derivatives MERCK SHARP &amp; DOHME LTD. (GB) 1992-09-02 EP disclosed
WO-1991013884-A2 SULFAMIDOSULFONAMIDE DERIVATIVES AND HERBICIDES NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-09-19 WO disclosed